With a senior partner network accumulating more than 250 years of combined experience and a C-level relationship portfolio cultivated over two decades, Aagami, Inc. operates as a high-access consultancy for life sciences organisations seeking to expand across borders. Headquartered in Naperville, Illinois, the firm has completed more than 200 assignments for over 110 clients spanning pharmaceuticals, biotechnology, medical devices and technology, consumer healthcare, CROs, CDMOs, and academia.
The core value proposition is bandwidth extension: Aagami supplements a client's in-house capability where geography, language, or resource constraints limit reach. Its four principal service lines are strategic consulting, technology licensing, business research and market intelligence, and business development support. A key differentiator is the firm's deep understanding of business and socio-cultural differences across global markets, enabling clients to navigate regulatory environments, commercial customs, and stakeholder expectations that vary significantly by region.
Clients engaging Aagami typically seek access to decision-makers that are difficult to approach through internal channels. The firm's approach centres on leveraging long-standing executive relationships and cross-sector experience to reduce the time, effort, and cost involved in international business development and technology licensing transactions. Its newsletter and publications programme, including the long-running Pullan's Pieces series, reflects the firm's commitment to sharing market intelligence with the broader life sciences community.
Further information is available at aagami.com.